What is Microgen Biotech?
Microgen Biotech is focused on enhancing food safety through the development of natural microbial solutions designed to mitigate heavy metal uptake in food crops. The company's innovative approach utilizes native, non-engineered microbes to reduce contaminants like arsenic and cadmium in agricultural produce. Microgen Biotech serves food businesses aiming to improve safety, reduce risk, and strengthen supply chain resilience. With successful field trials, the company is poised to make a substantial impact on global food quality and sustainability.
How much funding has Microgen Biotech raised?
Microgen Biotech has raised a total of $3.8M across 1 funding round:
Series A
$3.8M
Series A (2020): $3.8M with participation from SVG Ventures, Fulcrum Global Capital,, and The Yield Lab Europe
Key Investors in Microgen Biotech
SVG Ventures
SVG Ventures is an investor in Microgen Biotech's Series A round. Their involvement suggests a focus on agricultural technology and innovation.
Fulcrum Global Capital
Fulcrum Global Capital participated in Microgen Biotech's Series A funding, indicating an interest in companies with significant growth potential in the biotech sector.
The Yield Lab Europe
The Yield Lab Europe, an investor in Microgen Biotech's Series A, typically focuses on ag-tech and food-tech ventures, aligning with the company's mission.
What's next for Microgen Biotech?
The recent major strategic investment signifies a pivotal moment for Microgen Biotech, likely enabling the company to scale its operations, expand its research and development capabilities, and broaden its market reach. This enterprise-level funding suggests a transition towards commercialization and wider adoption of its food safety solutions. Future growth will likely involve strategic partnerships and further validation of its microbial technologies in diverse agricultural settings, solidifying its position as a leader in sustainable food safety.
See full Microgen Biotech company page
